Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis.
about
Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damagePeripheral blood mononuclear cell membrane fluidity and disease outcome in patients with multiple sclerosisAssessment of the Relationship Between Red Cell Distribution Width and Multiple Sclerosis.Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.Efficacy of fish oil on serum of TNF α , IL-1 β , and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b.A systematic review of the effects of modifiable risk factor interventions on the progression of multiple sclerosis.Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota.Brain phospholipid arachidonic acid half-lives are not altered following 15 weeks of N-3 polyunsaturated fatty acid adequate or deprived diet.Red blood cell membrane fluidity in the etiology of multiple sclerosis.Immune cell membrane fatty acids and inflammatory marker, C-reactive protein, in patients with multiple sclerosis.Membrane saturated fatty acids and disease progression in multiple sclerosis patients.The associations between dietary patterns and bone health, according to the TGF-β1 T869→C polymorphism, in postmenopausal Iranian women.
P2860
Q35028421-A0D86F71-7DCD-494E-A78D-7EC0FCF95AD4Q35851647-58967C92-C09C-4D16-B79A-66FC2220E4C2Q36153528-7DA8C031-683F-49C4-AF45-1D65583D4190Q36169584-DBAA38DF-801B-4A46-A4DC-509B9BC51337Q36989834-D209E49D-0CD5-4027-8F05-12C74796A092Q39115184-58867F1C-DC07-4B54-AE44-9A9A3AF36BE6Q41453198-786C9CF2-6354-4240-A5D4-92FB4EE54AA3Q42921801-D481C180-D56B-41A6-AB48-73F2EEA82D02Q43241641-FDECF360-54F6-4085-8E0D-72DC1131D00EQ46005294-C74AEA11-7EB0-4931-B9BF-19DB51C2A695Q48416647-CA076A41-400B-42BB-ADBF-33F24086F02EQ50055329-985E4431-9568-49CD-B302-2C8C82AD6198
P2860
Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis.
@en
type
label
Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis.
@en
prefLabel
Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis.
@en
P2860
P1476
Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis.
@en
P2093
Laurence S Harbige
Mohammad K Sharief
P2860
P304
P356
10.1017/S0007114507833010
P478
98 Suppl 1
P577
2007-10-01T00:00:00Z